{"id":"W4400239828","doi":"10.1007/s13555-024-01200-5","title":"Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations","year":2024,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"LEO Pharma; Bausch Health; Astellas Pharma; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; Ortho Dermatologics; Sanofi Genzyme; Incyte; Castle Biosciences; Dermira; Regeneron Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer","keywords":"Atopic dermatitis; Dermatology; Clinical Practice; Medicine; Family medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002209421,0.0001094065,0.0003179005,0.00006091635,0.0001147535,0.00001624999,0.00003939918,0.0001873393,0.0001114784],"category_scores_gemma":[0.0002662463,0.00007748177,0.0001273827,0.0001043024,0.0003524284,0.0001232725,0.00003065484,0.0002575978,0.00001022511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000110743,"about_ca_system_score_gemma":0.000149466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001476579,"about_ca_topic_score_gemma":0.000007006334,"domain_scores_codex":[0.9987341,0.000236632,0.0005539436,0.0002131056,0.00009755674,0.0001646459],"domain_scores_gemma":[0.9980356,0.00159042,0.00007988219,0.0001804109,0.00005779312,0.00005592035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001013073,0.001083549,0.09961284,0.001021763,0.001200628,0.003421161,0.0009347333,6.86659e-7,0.00001715556,0.6228403,0.2452287,0.02362541],"study_design_scores_gemma":[0.00639988,0.0001003361,0.278386,0.0004163492,0.0003489708,0.0119095,0.0008084891,0.0002905329,0.0008478994,0.03250455,0.6677913,0.0001961863],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.672802,0.0188655,0.001549033,0.2705225,0.003582601,0.003219574,0.00008507809,0.0001244843,0.02924923],"genre_scores_gemma":[0.9876896,0.003921244,0.002222191,0.005736087,0.0002244265,0.00007237167,0.00001409229,0.00001121714,0.0001088174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5903357,"threshold_uncertainty_score":0.3159615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03828749553093205,"score_gpt":0.3944068089206649,"score_spread":0.3561193133897329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}